The LYSARC conducts various clinical studies in the field of lymphomas and CLL/WM research in collaboration with the LYSA clinical research network.
The LYSARC has contributed to important scientific production on lymphomas and CLL/WM research by the LYSA clinical research network.
Accelerating lymphomas and CLL/WM research
The LYSARC, in collaboration with the LYSA independent clinical research network, conducts major clinical studies in the field of *lymphomas and CLL/WM research (Chronic lymphocytic leukemia, Waldenström’s macroglobulinemia). The AHL 2011 phase 3 study and the real-life study REALYSA are two examples of this. The results of the AHL 2011 study defined a new care standard for advanced Hodgkin lymphomas: the PET-guided treatment strategy. As for the REALYSA, this is an unprecedented real-life study with 6,000 French patients suffering from various types of lymphomas, monitored over a period of 9 years. Objectives: improving the available knowledge and opening the possibility of new lymphoma research projects.
News
Ensemble contre le lymphome
An independent network of clinical lymphomas and CLL/WM research professionals (CLL/WM), acknowledged as a Cooperating Group
An operational lymphomas and CLL/WM research structure that conducts the LYSA projects
